Panitumumab - PDFSEARCH.IO - Document Search Engine

Panitumumab
Results: 70

#	Item
21	ARTICLE Received 3 Oct 2014 \| Accepted 22 Dec 2014 \| Published 27 Feb 2015 DOI: [removed]ncomms7169 OPEN Add to Reading List Source URL: www.nature.com Language: English - Date: 2015-02-27 07:56:38 Tyrosine kinase receptors Oncology Epidermal growth factor receptor Ras subfamily Panitumumab HER2/neu Cetuximab Biology Medicine Oncogenes
22	Public Summary Document Application No[removed]Cetuximab and KRAS mutation testing under MBS 73330 Applicant: Merck Serono Australia Pty Ltd Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-16 20:01:29 Bristol-Myers Squibb Cetuximab KRAS Panitumumab Oncogenes Gastrointestinal cancer Ras subfamily Colorectal cancer HRAS Medicine Biology Oncology
23	[removed]efc-schedule.pdf Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-04 19:44:09 Bristol-Myers Squibb Cetuximab Docetaxel Pharmaceutical Benefits Scheme Medical prescription Chemotherapy Pharmacist Pharmacy Panitumumab Medicine Health Chemistry
24	Public Summary Document Application No[removed]KRAS mutation testing for panitumumab Sponsor/Applicant/s: Amgen Australia Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:51:26 Biotechnology Healthcare in Australia Bristol-Myers Squibb Cetuximab KRAS Panitumumab Colorectal cancer Biomarker Pharmaceutical Benefits Scheme Medicine Biology Health
25	Public Summary Document Application No[removed]KRAS mutation testing for panitumumab Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:51:26 Biotechnology Healthcare in Australia Bristol-Myers Squibb Cetuximab KRAS Panitumumab Colorectal cancer Biomarker Pharmaceutical Benefits Scheme Medicine Biology Health
26	Microsoft Word[removed]Final PSD - RAS testing for cetuximab-accessible.DOCX Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-16 20:01:28 Cetuximab KRAS Panitumumab Gastrointestinal cancer Ras subfamily Colorectal cancer HRAS Biomarker Mutation Medicine Biology Bristol-Myers Squibb
27	Public Summary Document Application 1363 – RAS (KRAS and NRAS) mutation testing for eligibility to access panitumumab Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-03 00:24:10 Cetuximab KRAS Panitumumab Oncogenes Gastrointestinal cancer Ras subfamily Colorectal cancer HRAS Biomarker Medicine Biology Bristol-Myers Squibb
28	Microsoft Word[removed]Final PSD - RAS testing for panitumumab-accessible.DOCX Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-03 00:24:10 KRAS Panitumumab Oncogenes Gastrointestinal cancer Ras subfamily Colorectal cancer HRAS Biomarker Cancer Medicine Bristol-Myers Squibb Cetuximab
29	Microsoft Word - JWE05130.doc Add to Reading List Source URL: jama.jamanetwork.com Language: English Bristol-Myers Squibb Cetuximab Oncogenes Carcinogenesis KRAS Ras subfamily Colorectal cancer Panitumumab Medicine Oncology Biology
30	ORIGINAL CONTRIBUTION Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab Add to Reading List Source URL: jama.jamanetwork.com Language: English Cetuximab Panitumumab KRAS Pfizer Amines Quinazolines Gastrointestinal cancer Erlotinib Colorectal cancer Medicine Chemistry Bristol-Myers Squibb

UPDATE